Adaptive biotechnologies corporation

NA

ADPT


1165 Eastlake Avenue East
Seattle , WA 98109

Executive/
Director

Price

  • Last Close
  • $ 7.19
    $ +1.01 16.34 %
    Jan 3, 2025
  • 52-Week High/Low
  • $6.81 - $2.34
  • YTD
  • 20%

  • Trading Volume
  • 39,645
  • Market Cap Full
  • $ 1B
  • Shares Outstanding
  • 144.8M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -33.5% -50.9% 15.6% -34.6% 20%
Q2 - - - - 4% 5.9% -42.6% -24% 10.9% -
Q3 - - - -24.3% 8% -16.8% -12% -18.8% 2.5% -
Q4 - - - -1.8% 20.6% -15.6% 7.3% -5.6% 5.6% -
J F M A M J J A S O N D
2025 20% - - - - - - - - - - -
2024 -25.1% 12% -22% -25% 43.9% - 31.8% 2.5% - - - 0.3%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%95%-51%-73%-36%22%20%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.41 - - - - -0.29 -0.44 -0.40
Q2 0.43 - - 1.23 - -0.35 -0.37 -0.33
Q3 - - - 0.11 - -0.4 -0.32 -0.35
Q4 - - - 0.17 - -0.44 -0.27 -
A 0.8 0 0 1.5 -1.1 -1.5 -1.4 -1.08

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - 126.3 139.2 141.6 143.2
Jun - 126.9 140.3 142.2 144.3
Sep 124.3 135.8 140.8 142.9 144.6
Dec 124.3 136.8 141.1 143 144.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 4.1 2.6 1.6 2.4 2.5
Fixed Asset Turnover 2.1 0.5 0.6 0.5 3
Total Asset Turnover 0.2 0.2 0.1 0.1 0.2
Leverage
Debt Ratio - - - 0.1 -
Debt – Equity Ratio - - - 0.1 -
Interest Coverage - 104.5 21.9 8.7 12.5
Equity multiplier 0.2 0.5 0.2 0.3 0.1